Casdin Capital’s Audentes Therapeutics, Inc BOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-860,000
| Closed | -$51.5M | – | 39 |
|
|
2019
Q4 | $51.5M | Hold |
860,000
| – | – | 4.73% | 9 |
|
|
2019
Q3 | $24.2M | Sell |
860,000
-105,000
| -11% | -$2.95M | 2.5% | 14 |
|
|
2019
Q2 | $36.5M | Sell |
965,000
-45,000
| -4% | -$1.7M | 3.42% | 13 |
|
|
2019
Q1 | $39.4M | Buy |
1,010,000
+150,000
| +17% | +$5.85M | 4.33% | 12 |
|
|
2018
Q4 | $18.3M | Buy |
860,000
+235,000
| +38% | +$5.01M | 3.14% | 14 |
|
|
2018
Q3 | $24.7M | Buy |
625,000
+175,000
| +39% | +$6.93M | 3.01% | 16 |
|
|
2018
Q2 | $17.2M | Hold |
450,000
| – | – | 2.4% | 18 |
|
|
2018
Q1 | $13.5M | Buy |
450,000
+50,000
| +13% | +$1.5M | 2.38% | 19 |
|
|
2017
Q4 | $12.5M | Hold |
400,000
| – | – | 3.04% | 16 |
|
|
2017
Q3 | $11.2M | Hold |
400,000
| – | – | 3.16% | 16 |
|
|
2017
Q2 | $7.65M | Buy |
400,000
+140,000
| +54% | +$2.68M | 2.83% | 14 |
|
|
2017
Q1 | $4.43M | Buy |
+260,000
| New | +$4.43M | 2.61% | 11 |
|